Bright Minds Biosciences financial statements
브라이트 마인즈 바이오사이언시스NASDAQ:DRUG · Nasdaq · Healthcare · sector #13$49.79-1.78%
2026-10-05 closeBright Minds Biosciences's published financial data is dated 2026-10-04. 2009 revenue was $166M. 2009 operating profit was $18M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy